ResMed, a manufacturer of CPAP machines for sleep apnoea, reports record revenue but its shares fall in response to margin pressure attributed to inflation. Multiple outlets say the company’s top-line performance is strong, yet the inflation impact reduces its gross profit margin, weighing on investor expectations. The reported share drop is close to five per cent, indicating a market reaction that focuses more on profitability trends than on revenue growth. While the company’s results show increased revenue, the sources agree that inflation is a key factor affecting costs and gross margins, which in turn influences the company’s overall financial performance. The coverage centers on the contrast between improved revenue and softer margin outcomes, with the share price decline reflecting concerns that inflation-related pressures may continue to affect profitability. Overall, the reports present a picture of a business delivering higher sales while facing near-term headwinds in cost and margin metrics.